Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up to $12.73

Phibro Animal Health Co. (NASDAQ:PAHC) gapped up prior to trading on Monday . The stock had previously closed at $12.73, but opened at $13.60. Phibro Animal Health shares last traded at $14.63, with a volume of 113,783 shares trading hands.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Tuesday, April 9th.

Phibro Animal Health Stock Performance

The company’s fifty day moving average is $12.83 and its 200 day moving average is $11.77. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66. The company has a market capitalization of $648 million, a P/E ratio of 35.36, a P/E/G ratio of 4.70 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 7th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The company had revenue of $249.90 million for the quarter, compared to analysts’ expectations of $242.91 million. As a group, equities analysts anticipate that Phibro Animal Health Co. will post 1.12 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.00%. Phibro Animal Health’s payout ratio is currently 133.33%.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds have recently bought and sold shares of the business. Brandes Investment Partners LP increased its stake in Phibro Animal Health by 38.5% in the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock worth $23,922,000 after buying an additional 520,697 shares during the period. Wellington Management Group LLP lifted its stake in Phibro Animal Health by 165.9% during the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after acquiring an additional 102,793 shares during the period. GSA Capital Partners LLP lifted its stake in shares of Phibro Animal Health by 227.0% in the 3rd quarter. GSA Capital Partners LLP now owns 81,647 shares of the company’s stock valued at $1,043,000 after purchasing an additional 56,676 shares during the period. BNP Paribas Financial Markets raised its position in Phibro Animal Health by 290.2% during the fourth quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock worth $849,000 after acquiring an additional 54,506 shares during the period. Finally, Brandywine Global Investment Management LLC raised its position in Phibro Animal Health by 21.1% during the third quarter. Brandywine Global Investment Management LLC now owns 257,200 shares of the company’s stock worth $3,284,000 after acquiring an additional 44,900 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.